Business Context and Reporting Period
Company: Eastman Kodak Company
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 1999
Business Overview: Kodak operates through four primary segments: Consumer Imaging, Kodak Professional, Health Imaging, and Other Imaging. The quarter was characterized by strong volume growth in consumer films and the integration of the Imation medical imaging acquisition, offset by strategic portfolio adjustments and charges related to exiting non-strategic businesses.
Key Financial Metrics
| Metric (in millions) | Q1 1999 | Q1 1998 |
|---|---|---|
| Sales | $3,100 | $2,911 |
| Gross Profit | $1,231 | $1,326 |
| Gross Margin | 39.7% | 45.6% |
| Earnings from Operations | $278 | $350 |
| Net Earnings | $191 | $225 |
| Diluted EPS | $0.59 | $0.69 |
| Cash and Equivalents | $338 | $489 |
| Net Cash Used in Operating Activities | ($110) | ($138) |
| Short-term Borrowings | $1,863 | $1,518 |
| Long-term Borrowings | $481 | $504 |
Material Changes vs. Prior Period
- Revenue Growth: Sales increased 6% year-over-year, driven by volume gains in consumer films (up 9% worldwide) and the inclusion of the Imation medical imaging business. Currency fluctuations favorably impacted sales by $34 million.
- Profitability Decline: Net earnings decreased 15% to $191 million. This decline was primarily due to $68 million in after-tax charges ($103 million pre-tax) related to portfolio adjustments, including the exit of the Eastman Software business and the Entertainment Imaging sticker print kiosk line.
- Adjusted Performance: Excluding the $68 million in charges, adjusted net earnings were $259 million ($0.80 per share), representing a 9% increase over the prior year's adjusted earnings of $237 million.
- Segment Performance:
- Consumer Imaging: Sales up 4%; Operating earnings up 50% to $141 million.
- Health Imaging: Sales up 41% (driven by Imation acquisition); Operating earnings up 4% to $100 million.
- Other Imaging: Sales down 4%; Operating earnings swung to a loss of $25 million from $88 million profit due to restructuring charges.
- Cash Flow: Net cash used in operating activities improved to $110 million from $138 million in the prior year, though still negative due to working capital changes and severance payments.
Guidance, Outlook, and Risks
- Cost Reduction Program: The Company anticipates achieving full-year net cost savings of $470 million in 1999, contributing to a total two-year savings target of $1.2 billion.
- Capital Expenditures: Total capital spending is projected at approximately $1.2 billion for 1999, with significant allocation to China manufacturing operations and productivity improvements.
- Stock Repurchase: On April 15, 1999, the Board authorized a new $2 billion stock repurchase program to be completed over up to four years.
- Divestitures: Kodak agreed to sell its digital printer, copier, and roller assembly operations to Heidelberger Druckmaschinen AG, effective April 1, 1999. The transaction is not expected to materially impact 1999 earnings.
- Year 2000 Compliance: The Company expects mission-critical IT systems to be compliant by mid-year 1999. Estimated remediation costs for 1999 are $12 million. Risks include potential third-party supplier failures.
- Legal and Environmental: A proposed administrative Consent Order from the New York State Department of Environmental Conservation regarding Kodak Park violations is pending, with an expected civil fine in excess of $100,000.
- Market Risks: Exposure to foreign currency exchange rates, silver price fluctuations, and interest rate changes. The introduction of the Euro is expected to create downward pressure on selling prices due to price harmonization.
Investor Verification Checklist
- Adjusted Earnings: Verify the $259 million adjusted net earnings figure and the specific breakdown of the $68 million in after-tax charges to understand core operational performance.
- Portfolio Exit Impact: Confirm the timeline and financial impact of the Eastman Software and sticker kiosk exits, and the expected earnings improvement post-exit.
- Imation Integration: Assess the long-term margin impact of the lower-margin Imation medical imaging business on the Health Imaging segment.
- Year 2000 Costs: Monitor actual remediation spending against the $12 million estimate for 1999 and the status of third-party supplier compliance.
- Capital Allocation: Track the execution of the new $2 billion stock repurchase program and the $1.2 billion capital expenditure plan, particularly regarding China operations.
- Working Capital: Review the $311 million decrease in liabilities (excluding borrowings) in the cash flow statement to understand the cash outflow related to severance and litigation settlements.